Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2011 3
2012 6
2013 7
2014 12
2015 8
2016 20
2017 16
2018 20
2019 26
2020 41
2021 30
2022 34
2023 34
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer.
Calibasi-Kocal G, Pakdemirli A, Bayrak S, Ozupek NM, Sever T, Basbinar Y, Ellidokuz H, Yigitbasi T. Calibasi-Kocal G, et al. J BUON. 2019 Jul-Aug;24(4):1482-1487. J BUON. 2019. PMID: 31646795 Free article.
The purpose of this study was to evaluate the antiproliferative, wound healing, anti-invasive and anti-migrative effects of curcumin on HCT-116 and LoVo colorectal cancer cell lines. METHODS: The antiproliferative activity of 2.5-75 M curcumin was tested on HCT-116 and LoV …
The purpose of this study was to evaluate the antiproliferative, wound healing, anti-invasive and anti-migrative effects of curcumin on HCT- …
Application of advanced technology in traditional Chinese medicine for cancer therapy.
Ke G, Zhang J, Gao W, Chen J, Liu L, Wang S, Zhang H, Yan G. Ke G, et al. Front Pharmacol. 2022 Oct 13;13:1038063. doi: 10.3389/fphar.2022.1038063. eCollection 2022. Front Pharmacol. 2022. PMID: 36313284 Free PMC article. Review.
With the continuous progress in cancer treatment, the overall efficacy of cancer therapy has been significantly improved, and the survival time of patients has been dramatically prolonged. In recent years, a series of advanced technologies, including nanotechnology, …
With the continuous progress in cancer treatment, the overall efficacy of cancer therapy has been significantly improved, and …
CD73 promotes cervical cancer growth via EGFR/AKT1 pathway.
Liu C, Gao ZW, Wang X, Lin F, Zhang HZ, Dong K. Liu C, et al. Transl Cancer Res. 2022 May;11(5):1089-1098. doi: 10.21037/tcr-21-2446. Transl Cancer Res. 2022. PMID: 35706815 Free PMC article.
BACKGROUND: Cervical cancer ranks third in cancer incidence worldwide and is the most frequent gynecological cancer in developing countries. ...CD73 has been implicated in the progression of many cancers. However, the study of CD73 in cervical cance …
BACKGROUND: Cervical cancer ranks third in cancer incidence worldwide and is the most frequent gynecological cancer in …
Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-kappaB/CCL2 signaling.
Jin L, Guo Y, Mao W, Wang J, Jin L, Liu X, Shou Q, Fu H. Jin L, et al. Phytomedicine. 2022 Sep;104:154307. doi: 10.1016/j.phymed.2022.154307. Epub 2022 Jul 2. Phytomedicine. 2022. PMID: 35841664
Therefore, in the present study, we investigated the mechanism via which TGP depresses tumor growth and metastasis via modulation of TAM infiltration in breast cancer. METHODS: We assessed the effects of TGP on various mouse models of tumor. ...Furthermore, conditional med …
Therefore, in the present study, we investigated the mechanism via which TGP depresses tumor growth and metastasis via modulation of TAM inf …
Cardiomyocyte Impedance Assays.
Lamore SD, Scott CW, Peters MF. Lamore SD, et al. 2015 Feb 25. In: Markossian S, Grossman A, Arkin M, Auld D, Austin C, Baell J, Brimacombe K, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Haas JV, Hall MD, Hoare S, Inglese J, Iversen PW, Lal-Nag M, Li Z, Manro JR, McGee J, McManus O, Pearson M, Riss T, Saradjian P, Sittampalam GS, Tarselli M, Trask OJ Jr, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004–. 2015 Feb 25. In: Markossian S, Grossman A, Arkin M, Auld D, Austin C, Baell J, Brimacombe K, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Haas JV, Hall MD, Hoare S, Inglese J, Iversen PW, Lal-Nag M, Li Z, Manro JR, McGee J, McManus O, Pearson M, Riss T, Saradjian P, Sittampalam GS, Tarselli M, Trask OJ Jr, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004–. PMID: 25855850 Free Books & Documents. Review.
Cellular impedance assays have been broadly utilized as a label-free approach for toxicity and drug discovery screening. The xCELLigence RTCA Cardio instrument sets itself apart from other impedance technologies by its rapid data acquisition rate (12.9 msec). ...A protocol …
Cellular impedance assays have been broadly utilized as a label-free approach for toxicity and drug discovery screening. The xCELLigence …
Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles.
Guler Kara H, Ozates NP, Asik A, Gunduz C. Guler Kara H, et al. Med Oncol. 2023 Oct 27;40(12):342. doi: 10.1007/s12032-023-02210-7. Med Oncol. 2023. PMID: 37891391
Ovarian cancer, often referred to as the 'silent killer,' is a significant contributor to mortality rates. ...The cytotoxicity of Amcasertib was assessed in both ovarian cancer and cancer stem cell models utilizing the Xelligence-RTCA system. ...
Ovarian cancer, often referred to as the 'silent killer,' is a significant contributor to mortality rates. ...The cytotoxicity of Amc …
Prognostic value of small mother against decapentaplegic expression in human gastric cancer.
Zhang HW, Guo Y, Sun LX, Ni FB, Xu K. Zhang HW, et al. Bioengineered. 2021 Dec;12(1):2534-2549. doi: 10.1080/21655979.2021.1935192. Bioengineered. 2021. PMID: 34138687 Free PMC article.
Gastric cancer is the fifth most common malignancy in the world with alow 5-year survival rate. ...Clinical data such as stage, differentiation, gender, treatment, and Her2 mutation status of gastric cancer patients were analyzed. The (E)-SIS3 was used to inhibit SM …
Gastric cancer is the fifth most common malignancy in the world with alow 5-year survival rate. ...Clinical data such as stage, diffe …
Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA).
El-Hajjar L, Shaito A, Jalaleddine N, Zibara K, Kazan JM, El-Saghir J, El-Sabban M. El-Hajjar L, et al. Data Brief. 2018 Dec 21;22:635-638. doi: 10.1016/j.dib.2018.12.059. eCollection 2019 Feb. Data Brief. 2018. PMID: 30671510 Free PMC article.
Bevacizumab or Avastin (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to …
Bevacizumab or Avastin (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breas …
A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer.
Lyu XD, Liu Y, Wang J, Wei YC, Han Y, Li X, Zhang Q, Liu ZR, Li ZZ, Jiang JW, Hu HL, Yuan ST, Sun L. Lyu XD, et al. Cancers (Basel). 2023 Oct 20;15(20):5082. doi: 10.3390/cancers15205082. Cancers (Basel). 2023. PMID: 37894450 Free PMC article.
BACKGROUND: The microtubule protein inhibitor C118P shows excellent anti-breast cancer effects. However, the potential targets and mechanisms of C118P in breast cancer remain unknown. ...CONCLUSION: C118P exerts an antitumour effect against breast cancer via …
BACKGROUND: The microtubule protein inhibitor C118P shows excellent anti-breast cancer effects. However, the potential targets and me …
Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.
Lin M, Xiao Y, Dai Y, Mao Y, Xu L, Zhang Q, Chen Z. Lin M, et al. Clin Transl Oncol. 2024 Apr;26(4):951-965. doi: 10.1007/s12094-023-03328-w. Epub 2023 Oct 18. Clin Transl Oncol. 2024. PMID: 37848695
BACKGROUND: Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. ...We have explored the impact of chloroxine on pancreatic cancer growth, infiltration, migration, and apoptosis. METHODS: The proliferation of pancrea …
BACKGROUND: Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. ...We have explore …
239 results